ZHEJIANG NOVUS PHARM
PharmaZHEJIANG NOVUS PHARM is a pharmaceutical company focused on Infectious Disease, Dermatology.
ZHEJIANG NOVUS PHARM's Key Drugs
ZHEJIANG NOVUS PHARM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
ZHEJIANG NOVUS PHARM's Recent FDA Approvals
New NDA/BLA approvals for ZHEJIANG NOVUS PHARM over the last two years — novel drugs only, excluding generics and label supplements.
ZHEJIANG NOVUS PHARM's Therapeutic Areas
ZHEJIANG NOVUS PHARM's approved drugs and pipeline span 2 therapeutic areas, led by Infectious Disease and Dermatology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
ZHEJIANG NOVUS PHARM's Top Competitors
ZHEJIANG NOVUS PHARM's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Baxter, and B BRAUN. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
ZHEJIANG NOVUS PHARM Pipeline Snapshot
Active clinical trials for ZHEJIANG NOVUS PHARM across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Infectious Disease pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2023-01-20
- Latest
- 2026-05-05
- Applications
- 2